Pioglitazone and oral cancer risk in patients with type 2 diabetes

Oral Oncology

Volumn 50, Issue 2, 2014, Pages 98-103

  Tseng, Chin Hsiao ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Diabetes mellitus; Oral cancer; Pioglitazone; Taiwan

Indexed keywords

INSULIN; PIOGLITAZONE;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH CANCER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; TAIWAN; TREATMENT DURATION;

DIABETES MELLITUS; ORAL CANCER; PIOGLITAZONE; TAIWAN;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RISK FACTORS; TAIWAN; THIAZOLIDINEDIONES;

EID: 84891824463     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.10.015     Document Type: Article

References (20)

1. N.M. Begum, K. Nakashiro, H. Kawamata, D. Uchida, S. Shintani, and Y. Ikawa et al. Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines Int J Oncol 20 2002 599 605
2. K. Nakashiro, N.M. Begum, D. Uchida, H. Kawamata, S. Shintani, and M. Sato et al. Thiazolidinediones inhibit cell growth of human oral squamous cell carcinoma in vitro independent of peroxisome proliferator-activated receptor gamma Oral Oncol 39 2003 855 861
3. N.G. Nikitakis, H. Siavash, C. Hebert, M.A. Reynolds, A.W. Hamburger, and J.J. Sauk 15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells Br J Cancer 87 2002 1396 1403
4. R. Suzuki, H. Kohno, M. Suzui, N. Yoshimi, H. Tsuda, and K. Wakabayashi et al. An animal model for the rapid induction of tongue neoplasms in human c-Ha-ras proto-oncogene transgenic rats by 4-nitroquinoline 1-oxide: its potential use for preclinical chemoprevention studies Carcinogenesis 27 2006 619 630
5. J.L. Hatton, and L.D. Yee Clinical use of PPARgamma ligands in cancer PPAR Res 2008 2008 159415
6. J.D. Lewis, A. Ferrara, T. Peng, M. Hedderson, W.B. Bilker, and C.P. Quesenberry Jr et al. Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study Diabetes Care 34 2011 916 922
7. J.A. Dormandy, B. Charbonnel, D.J. Eckland, E. Erdmann, M. Massi-Benedetti, and I.K. Moules et al. PROactive investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (PROspective pioglitAzone clinical trial in macrovascular events): a randomised controlled trial Lancet 366 2005 1279 1289
8. S.E. Nissen, and K. Wolski Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes N Engl J Med 356 2007 2457 2471
9. C.H. Tseng Oral cancer in Taiwan: is diabetes a risk factor? Clin Oral Investig 17 2013 1357 1364
10. C.H. Tseng Rosiglitazone is not associated with an increased risk of bladder cancer Cancer Epidemiol 37 2013 385 389
11. C.H. Tseng New-onset diabetes with a history of dyslipidemia predicts pancreatic cancer Pancreas 42 2013 42 48
12. C.H. Tseng Pioglitazone and bladder cancer in human studies: is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities? J Formos Med Assoc 111 2012 123 131
13. R.N. Sharan, R. Mehrotra, Y. Choudhury, and K. Asotra Association of betel nut with carcinogenesis: revisit with a clinical perspective PLoS ONE 7 2012 e42759
14. C.H. Tseng Betel nut chewing is associated with hypertension in Taiwanese type 2 diabetic patients Hypertens Res 31 2008 417 423
15. K.J. van Stralen, F.W. Dekker, C. Zoccali, and K.J. Jager Confounding Nephron Clin Pract 116 2010 c143 7
16. J. Sivasithamparam, C.A. Visk, E.E. Cohen, and A.C. King Modifiable risk behaviors in patients with head and neck cancer Cancer 119 2013 2419 2426
17. C.F. Hwang, C.C. Huang, C.Y. Chien, S.C. Huang, C.H. Yang, and C.Y. Su Human papillomavirus infection in oral papillary and verrucous lesions is a prognostic indicator of malignant transformation Cancer Epidemiol 36 2012 e122 7
18. C.Y. Chuang, W.W. Sung, L. Wang, W.L. Lin, K.T. Yeh, and M.C. Su et al. Differential impact of IL-10 expression on survival and relapse between HPV16-positive and -negative oral squamous cell carcinomas PLoS ONE 7 2012 e47541
19. L.A. Lee, C.G. Huang, C.T. Liao, L.Y. Lee, C. Hsueh, and T.C. Chen et al. Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival PLoS ONE 7 2012 e40767
20. A.I. Zavras, P. Shanmugam, D. Shetty, T.A. Dolecek, and L.M. Kaste Oral and pharyngeal cancer in women Dent Clin North Am 57 2013 339 355